Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina

被引:6
|
作者
Esteso, Federico [1 ]
Soledad Tissera, Natalia [1 ]
Manuel O'Connor, Juan [1 ]
Luca, Romina [1 ]
Huertas, Eduardo [2 ]
Sanchez Loria, Fernando [2 ]
Pedraza, Ivana [2 ]
Pairola, Alejandro [2 ]
Brancato, Fernando [2 ]
Paganini, Lisandro [3 ]
Kucharczyk, Mariana [3 ]
Amat, Mora [4 ]
Teresa Pombo, Maria [4 ]
Galli, Mariana [5 ]
Bruno, Luisina [1 ]
Caro, Luis [6 ]
Rodriguez, Andres [7 ]
Enrico, Diego [7 ]
Waisberg, Federico [7 ]
Chacon, Matias [7 ]
机构
[1] Inst Alexander Fleming, Dept Gastrointestinal Med Oncol, 1180 Cramer, RA-1426 Buenos Aires, DF, Argentina
[2] Inst Alexander Fleming, Dept Surg, RA-1426 Buenos Aires, DF, Argentina
[3] Inst Alexander Fleming, Dept Radiol, RA-1426 Buenos Aires, DF, Argentina
[4] Inst Alexander Fleming, Dept Pathol, RA-1426 Buenos Aires, DF, Argentina
[5] Inst Alexander Fleming, Dept Radiat Oncol, RA-1426 Buenos Aires, DF, Argentina
[6] Inst Alexander Fleming, Dept Gastroenterol, RA-1426 Buenos Aires, DF, Argentina
[7] Inst Alexander Fleming, Dept Med Oncol, RA-1426 Buenos Aires, DF, Argentina
来源
WORLD JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 13卷 / 06期
关键词
Tumor board; Virtual; Gastrointestinal; Cancer disparities; Oncology; Extension for Comm Healthcare Outcomes project;
D O I
10.5306/wjco.v13.i6.423
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Given the increasing complexity of cancer care, multidisciplinary tumor boards have become essential in daily clinical oncology practice. The Project Extension for Community Healthcare Outcomes (ECHO) initiative developed an innovative telementoring model using a "hub and spoke" design consisting of a team of experts (hub) that offers a full service to multiple participants (the spokes) during regularly scheduled sessions discussing patients' clinical cases. The Alexander Fleming Cancer Institute in Buenos Aires was the first hub in Latin America to implement Project ECHO for gastrointestinal tumors. In our 3-year experience, 80 patients from 37 centers were evaluated within Project ECHO and a range of three to five cases were discussed in each meeting. From our perspective, the impact of this novel approach was a remarkable strategy to reduce care disparities by equalizing access to high-quality medical knowledge in a multidisciplinary environment for medical discussions. Additionally, it was shown to have a cost-effective impact directly on the patients and the local health system, since relevant costs were saved after unnecessary treatments, studies and travel expenses were avoided.
引用
收藏
页码:423 / 428
页数:6
相关论文
共 50 条
  • [41] Improved Breast Cancer Care Quality Metrics After Implementation of a Standardized Tumor Board Documentation Template
    Farrugia, Daniel J.
    Fischer, Trevan D.
    Delitto, Daniel
    Spiguel, Lisa R. P.
    Shaw, Christiana M.
    JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (05) : 421 - +
  • [42] Implementation of Next Generation Sequencing-based Molecular Diagnostics in a Lung Cancer Center Tumor Board
    Frangenberg, A.
    Starbatty, B.
    Berressem, S.
    Frangenberg, A.
    Sueptitz, J.
    Hayn, A.
    Hagmeyer, L.
    Wragge, S.
    Hellmessen, K.
    Merkelbach-Bruse, S.
    Ueckeroth, F.
    Hekmat, K.
    Frank, K.
    Randerath, W.
    Buettner, R.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 117 - 117
  • [43] Implementation of a molecular tumor board -two year's experience at the Cancer Center Heilbronn-Franken
    Vladimirova, D.
    Bochum, S.
    Finkeisen, D.
    Schilliro, A.
    Zsebedits, D.
    Fegeler, C.
    Biskup, S.
    Martens, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 50 - 50
  • [44] Overcoming Barriers to Implementation of Gastric Cancer Surgical Standards Through Tumor Board Engagement: Stakeholder Input
    Mehta, Shivani
    Shenvi, Edna
    Blair, Sarah
    Caudle, Abigail
    Lowenstein, Lisa
    Kelly, Kaitlyn J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 359 - 359
  • [45] The Virtual Molecular Tumor Board of the Variant Interpretation for Cancer Consortium: A systematic gateway connecting cancer genome interpretation and progress in genomic knowledgebases in cancer
    Pitel, Beth A.
    Rao, Shruti
    Fitz, Catherine Del Vecchio
    Madhavan, Subha
    Dientsmann, Rodrigo
    Horak, Peter
    King, Ian
    Mockus, Susan M.
    Raca, Gordana
    Rieke, Damian T.
    Rogan, Peter
    Sonkin, Dmitriy
    Tamborero, David
    Vlachos, Ioannis S.
    Walsh, Brian
    Warner, Jeremy L.
    Griffith, Malachi
    Griffith, Obi L.
    Chakravarty, Debyani
    Wagner, Alex H.
    CANCER RESEARCH, 2020, 80 (16)
  • [46] LET'S TALK ABOUT IT: NURSE NAVIGATOR EXPEDITES COMPREHENSIVE CANCER CARE THROUGH IMPLEMENTATION OF A TUMOR BOARD
    Hammer, Amber
    Bruce, Susan
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [47] The evolution of patient navigation research models to reduce breast cancer disparities: Case studies of patient navigation dissemination and implementation in Chicago
    Simon, Melissa A.
    Tom, Laura S.
    Trosman, Julia R.
    Weldon, Christine B.
    O'Brian, Catherine A.
    Kirschner, Marcie C.
    Dong, XinQi
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Tumor Budding in Colorectal Cancer: A Multicenter Inter-Observer Study on Behalf of the Swiss Association of Gastrointestinal Pathology (SAGIP)
    Koelzer, Viktor
    Zlobec, Inti
    Berger, Martin
    Cathomas, Gieri
    Dawson, Heather
    Dirschmid, Klaus
    Hadrich, Marion
    Inderbitzin, Daniel
    Offner, Felix
    Puppa, Giacomo
    Seelentag, Walter
    Schnuriger, Beat
    Tornillo, Luigi
    Lugli, Alessandro
    MODERN PATHOLOGY, 2015, 28 : 171A - 171A
  • [49] Tumor Budding in Colorectal Cancer: A Multicenter Inter-Observer Study on Behalf of the Swiss Association of Gastrointestinal Pathology (SAGIP)
    Koelzer, Viktor
    Zlobec, Inti
    Berger, Martin
    Cathomas, Gieri
    Dawson, Heather
    Dirschmid, Klaus
    Hadrich, Marion
    Inderbitzin, Daniel
    Offner, Felix
    Puppa, Giacomo
    Seelentag, Walter
    Schnuriger, Beat
    Tornillo, Luigi
    Lugli, Alessandro
    LABORATORY INVESTIGATION, 2015, 95 : 171A - 171A
  • [50] Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center
    Toegel, Lars
    Schubart, Christoph
    Lettmaier, Sebastian
    Neufert, Clemens
    Hoyer, Juliane
    Wolff, Kerstin
    Moskalev, Evgeny A.
    Stoehr, Robert
    Agaimy, Abbas
    Reis, Andre
    Wullich, Bernd
    Mackensen, Andreas
    Pavel, Marianne
    Beckmann, Matthias W.
    Hartmann, Arndt
    Fietkau, Rainer
    Meidenbauer, Norbert
    Haller, Florian
    Spoerl, Silvia
    CANCERS, 2023, 15 (24)